A Philadelphia judge correctly instructed the jury in a hormone replacement therapy case that it had to decide if the drug Prempro was a factual cause in the plaintiff’s "development of … breast cancer," the state Superior Court has ruled.
Plaintiffs counsel seeking a more broadly-worded instruction in the products liability trial over the effects of HRT in older female patients had wanted the jury to be instructed by Philadelphia Court of Common Pleas Judge James Murray Lynn that it had to decide if Prempro was a factual cause of harm to the patient. The jury returned a defense verdict in Henry v. Wyeth.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
